Investor Presentaiton slide image

Investor Presentaiton

India Business at a glance Market Position** Prescription Ranking## Chronic Segment • No. 1 in India • No. 1 ranked with 8.9% market share • Growth of 15% versus average industry growth of 14% • No. 1 ranked by prescriptions with 13 different classes of doctors Market leader in the chronic segment Acute Segment • Strong positioning in the acute segment SUN PHARMA Product Offering Strong Brand Positioning** De-risked Growth** Extensive Sales Force **- As per AIOCD AWACS data for 12 months ended Sept'15 ## - As per SMSRC data for June'15 © Sun Pharmaceutical Industries Limited. All Rights Reserved. • Specializes in technically complex products and offers a complete therapy basket • 30 brands in the country's top 300 pharmaceutical brands • Top 10 Brands contribute approx. 15% of India revenues • Growth driven by a basket of brands & not few key brands • 9,000+ strong field force covering over 600,000* doctors * Does not exclude overlaps 21
View entire presentation